Erythropoietin for the repair of cerebral injury in very preterm infants (EpoRepair)

Neonatology

Volumn 108, Issue 3, 2015, Pages 198-204

  Rüegger, Christoph M ^b   Hagmann, Cornelia F ^b   Bührer, Christoph ^d   Held, Leonhard ^c   Bucher, Hans Ulrich ^b   Wellmann, Sven ^a,b  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Brain damage; Children; Development; Drug; Neurology

Indexed keywords

PLACEBO; RECOMBINANT ERYTHROPOIETIN;

ARTICLE; BRAIN HEMORRHAGE; BRAIN INJURY; COGNITION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MEGADOSE; ECHOENCEPHALOGRAPHY; FOLLOW UP; HUMAN; INFANT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REPEATED DRUG DOSE; CEREBRAL HEMORRHAGE, TRAUMATIC; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; FEMALE; MALE; PATIENT SELECTION; PHASE 3 CLINICAL TRIAL; VERY LOW BIRTH WEIGHT; WHITE MATTER;

CEREBRAL HEMORRHAGE, TRAUMATIC; DOUBLE-BLIND METHOD; EPOETIN ALFA; FEMALE; HUMANS; INFANT; INFANT, PREMATURE; INFANT, VERY LOW BIRTH WEIGHT; MAGNETIC RESONANCE IMAGING; MALE; PATIENT SELECTION; WHITE MATTER;

EID: 84942818815     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000437248     Document Type: Article

References (46)

1. Brouwer AJ, Groenendaal F, Benders MJ, de Vries LS: Early and late complications of germinal matrix-intraventricular haemorrhage in the preterm infant: what is new? Neonatology 2014; 106: 296-303
2. O'Shea TM, Allred EN, Kuban KC, Hirtz D, Specter B, Durfee S, Paneth N, Leviton A; ELGAN Study Investigators: Intraventricular hemorrhage and developmental outcomes at 24 months of age in extremely preterm infants. J Child Neurol 2012; 27: 22-29
3. Vassilyadi M, Tataryn Z, Shamji MF, Ventureyra EC: Functional outcomes among premature infants with intraventricular hemorrhage. Pediatr Neurosurg 2009; 45: 247-255
4. Papile LA, Burstein J, Burstein R, Koffler H: Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 g. J Pediatr 1978; 92: 529-534
5. Volpe JJ: Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol 2009; 8: 110-124
6. Adams-Chapman I, Hansen NI, Stoll BJ, Higgins R: Neurodevelopmental outcome of extremely low birth weight infants with posthemorrhagic hydrocephalus requiring shunt insertion. Pediatrics 2008; 121:e1167-1177
7. Payne AH, Hintz SR, Hibbs AM, Walsh MC, Vohr BR, Bann CM, Wilson-Costello DE; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network: Neurodevelopmental outcomes of extremely low-gestationalage neonates with low-grade periventricularintraventricular hemorrhage. JAMA Pediatr 2013; 167: 451-459
8. Bolisetty S, Dhawan A, Abdel-Latif M, Bajuk B, Stack J, Lui K; New South W, Australian Capital Territory Neonatal Intensive Care Units Data Collection: Intraventricular hemorrhage and neurodevelopmental outcomes in extreme preterm infants. Pediatrics 2014; 133: 55-62
9. Srinivasan L, Allsop J, Counsell SJ, Boardman JP, Edwards AD, Rutherford M: Smaller cerebellar volumes in very preterm infants at term-equivalent age are associated with the presence of supratentorial lesions. AJNR Am J Neuroradiol 2006; 27: 573-579
10. Meng H, Li F, Hu R, Yuan Y, Gong G, Hu S, Feng H: Deferoxamine alleviates chronic hydrocephalus after intraventricular hemorrhage through iron chelation and Wnt1/ Wnt3a inhibition. Brain Res 2015; 1602: 44-52
11. Dean JM, Bennet L, Back SA, McClendon E, Riddle A, Gunn AJ: What brakes the preterm brain? An arresting story. Pediatr Res 2014; 75: 227-233
12. Morita T, Morimoto M, Yamada K, Hasegawa T, Morioka S, Kidowaki S, Moroto M, Yamashita S, Maeda H, Chiyonobu T, Tokuda S, Hosoi H: Low-grade intraventricular hemorrhage disrupts cerebellar white matter in preterm infants: evidence from diffusion tensor imaging. Neuroradiology 2015; 57: 507-14
13. Ou X, Glasier CM, Ramakrishnaiah RH, Mulkey SB, Ding Z, Angtuaco TL, Andres A, Kaiser JR: Impaired white matter development in extremely low-birth-weight infants with previous brain hemorrhage. AJNR Am J Neuroradiol 2014; 35: 1983-1989
14. Thompson DK, Lee KJ, Egan GF, Warfield SK, Doyle LW, Anderson PJ, Inder TE: Regional white matter microstructure in very preterm infants: predictors and 7-year outcomes. Cortex 2014; 52: 60-74
15. Felderhoff-Mueser U, Buhrer C: Clinical measures to preserve cerebral integrity in preterm infants. Early Hum Dev 2005; 81: 237-244
16. Sasaki Y, Ikeda T, Nishimura K, Katsuragi S, Sengoku K, Kusuda S, Fujimura M: Association of antenatal corticosteroids and the mode of delivery with the mortality and morbidity of infants weighing less than 1,500 g at birth in Japan. Neonatology 2014; 106: 81-86
17. Fowlie PW, Davis PG: Prophylactic indomethacin for preterm infants: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 2003; 88:F464-F466
18. Whitelaw A, Jary S, Kmita G, Wroblewska J, Musialik-Swietlinska E, Mandera M, Hunt L, Carter M, Pople I: Randomized trial of drainage, irrigation and fibrinolytic therapy for premature infants with posthemorrhagic ventricular dilatation: developmental outcome at 2 years. Pediatrics 2010; 125:e852-e858
19. Schulz M, Buhrer C, Pohl-Schickinger A, Haberl H, Thomale UW: Neuroendoscopic lavage for the treatment of intraventricular hemorrhage and hydrocephalus in neonates. J Neurosurg Pediatr 2014; 13: 626-635
20. Kaneko N, Kako E, Sawamoto K: Enhancement of ventricular-subventricular zone-derived neurogenesis and oligodendrogenesis by erythropoietin and its derivatives. Front Cell Neurosci 2013; 7: 235
21. Kako E, Kaneko N, Aoyama M, Hida H, Takebayashi H, Ikenaka K, Asai K, Togari H, Sobue K, Sawamoto K: Subventricular zone-derived oligodendrogenesis in injured neonatal white matter in mice enhanced by a nonerythropoietic erythropoietin derivative. Stem Cells 2012; 30: 2234-2247
22. van de Looij Y, Chatagner A, Quairiaux C, Gruetter R, Huppi PS, Sizonenko SV: Multimodal assessment of long-term erythropoietin treatment after neonatal hypoxic-ischemic injury in rat brain. PLoS One 2014; 9:e95643
23. Neubauer AP, Voss W, Wachtendorf M, Jungmann T: Erythropoietin improves neurodevelopmental outcome of extremely preterm infants. Ann Neurol 2010; 67: 657-666
24. Brines M, Cerami A: The receptor that tames the innate immune response. Mol Med 2012; 18: 486-496
25. Aher SM, Ohlsson A: Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2014; 4:CD004868
26. Ohlsson A, Aher SM: Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2014; 4:CD004863
27. Rangarajan V, Juul SE: Erythropoietin: emerging role of erythropoietin in neonatal neuroprotection. Pediatr Neurol 2014; 51: 481-488
28. Fauchere JC, Koller B, Tschopp A, Dame C, Rueegger CM, Bucher HU: Safety of early high-dose recombinant erythropoietin for neuroprotection in very preterm infants. J Pediatr 2015; 167: 52-57
29. Leuchter RH, Gui L, Poncet A, Hagmann C, Lodygensky GA, Martin E, Koller B, Darque A, Bucher HU, Huppi PS: Association between early administration of high-dose erythropoietin in preterm infants and brain MRI abnormality at term-equivalent age. JAMA 2014; 312: 817-824
30. O'Gorman RL, Bucher HU, Held U, Koller BM, Huppi PS, Hagmann CF; Swiss EPO Neuroprotection Trial Group: Tract-based spatial statistics to assess the neuroprotective effect of early erythropoietin on white matter development in preterm infants. Brain 2015; 138: 388-397
31. Abbott A: Neuroscience: the brain, interrupted. Nature 2015; 518: 24-26
32. Marlow N: Is survival and neurodevelopmental impairment at 2 years of age the gold standard outcome for neonatal studies? Arch Dis Child Fetal Neonatal Ed 2015; 100:F82-F84
33. Juul SE, McPherson RJ, Bauer LA, Ledbetter KJ, Gleason CA, Mayock DE: A phase I/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety. Pediatrics 2008; 122: 383-391
34. Wu YW, Bauer LA, Ballard RA, Ferriero DM, Glidden DV, Mayock DE, Chang T, Durand DJ, Song D, Bonifacio SL, Gonzalez FF, Glass HC, Juul SE: Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics. Pediatrics 2012; 130: 683-691
35. Melchers P, Preuss U: Kaufman Assessment Battery for Children (German version). Frankfurt am Main, Pearson Assessment, 2009
36. Natalucci G, Seitz J, von Siebenthal K, Bucher HU, Molinari L, Jenni OG, Latal B: The role of birthweight discordance in the intellectual and motor outcome for triplets at early school age. Dev Med Child Neurol 2011; 53: 822-828
37. Tellegen PJ, Laros JA, Petermann F: Snijders-Oomen non-verbaler Intelligenztest von 2,5 bis 7 Jahre (SON-R 2,5-7): Testbatterie zur sprachfreien Messung der allgemeinen Intelligent. Goettingen, Hogrefe, 2007
38. Schmidt B, Anderson PJ, Doyle LW, Dewey D, Grunau RE, Asztalos EV, Davis PG, Tin W, Moddemann D, Solimano A, Ohlsson A, Barrington KJ, Roberts RS; Caffeine for Apnea of Prematurity Trial Investigators: Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity. JAMA 2012; 307: 275-282
39. Brouwer MJ, van Kooij BJ, van Haastert IC, Koopman-Esseboom C, Groenendaal F, de Vries LS, Benders MJ: Sequential cranial ultrasound and cerebellar diffusion weighted imaging contribute to the early prognosis of neurodevelopmental outcome in preterm infants. PLoS One 2014; 9:e109556
40. Johnson S, Moore T, Marlow N: Using the Bayley-III to assess neurodevelopmental delay: which cut-off should be used? Pediatr Res 2014; 75: 670-674
41. Vickers AJ, Altman DG: Statistics notes: missing outcomes in randomised trials. BMJ 2013; 346:f3438
42. de Vries LS, van Haastert IC, Benders MJ, Groenendaal F: Myth: Cerebral palsy cannot be predicted by neonatal brain imaging. Semin Fetal Neonatal Med 2011; 16: 279-287
43. Johnson S, Hennessy E, Smith R, Trikic R, Wolke D, Marlow N: Academic attainment and special educational needs in extremely preterm children at 11 years of age: the EPICure study. Arch Dis Child Fetal Neonatal Ed 2009; 94:F283-F289
44. Ohls RK, Christensen RD: Stability of human recombinant epoetin alfa in commonly used neonatal intravenous solutions. Ann Pharmacother 1996; 30: 466-468
45. Huynh-Delerme C, Penaud JF, Lacombe C, Brunhes A, Moriette G: Stability and biological activity of epoietin beta in parenteral nutrition solutions. Biol Neonate 2002; 81: 158-162
46. Naughton CA, Duppong LM, Forbes KD, Sehgal I: Stability of multidose, preserved formulation epoetin alfa in syringes for three and six weeks. Am J Health Syst Pharm 2003; 60: 464-468